China SXT Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
China SXT Pharmaceuticals has a total shareholder equity of $13.9M and total debt of $3.5M, which brings its debt-to-equity ratio to 24.8%. Its total assets and total liabilities are $23.1M and $9.2M respectively.
Key information
24.8%
Debt to equity ratio
US$3.46m
Debt
| Interest coverage ratio | n/a |
| Cash | US$12.07m |
| Equity | US$13.93m |
| Total liabilities | US$9.20m |
| Total assets | US$23.13m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: SXTC's short term assets ($14.2M) exceed its short term liabilities ($8.9M).
Long Term Liabilities: SXTC's short term assets ($14.2M) exceed its long term liabilities ($294.7K).
Debt to Equity History and Analysis
Debt Level: SXTC has more cash than its total debt.
Reducing Debt: SXTC's debt to equity ratio has reduced from 25.1% to 24.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SXTC has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: SXTC has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 18.7% each year.